JDC Group AG header image

JDC Group AG

JDC

Equity

ISIN DE000A0B9N37 / Valor 2351305

Xetra (2026-10-06)
EUR 16.00+1.27%

JDC Group AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

JDC Group AG is a Germany-based financial services and insurtech company that builds and operates digital distribution and back-office platforms for the insurance and pension market. It supplies software and services—broker portals, product-comparison and marketplace tools, contract administration, customer-facing portals and advisory systems—that help independent brokers, banks and institutional clients manage sales, advice and policy administration across life, health and property & casualty products. By aggregating insurer offers and supporting intermediaries’ workflows, compliance and reporting, JDC monetizes through commissions, platform and service fees and positions itself as a technology-driven intermediary connecting insurers with distribution partners.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (02.09.2026):

JDC Group AG — Q2 2026: The company reported strong sequential and year‑on‑year improvement in the second quarter of 2026, with revenues and EBITDA rising sharply according to its own releases tied to the Half‑yearly financial statements 2026 (18 August 2026).

Revenue growth

Revenues in Q2 2026 increased by 17% year‑on‑year; on an adjusted basis the company reports revenue growth of 25.5%.

EBITDA performance

EBITDA rose materially in Q2 2026 — reported increase of 83% year‑on‑year, with adjusted EBITDA reported to have increased by more than 100%.

Quarterly milestone (Q1 context)

JDC reported that in Q1 2026 it achieved approximately EUR 75 million in quarterly revenue for the first time, with EBITDA up by more than 60% in that quarter.

Operating context and strategic actions

The company describes the development as dynamic despite a challenging environment and highlights continued focus on scaling its platform business and strengthening governance (board-level actions reported in May/June 2026).

Source and next steps for investors

These figures come from JDC Group AG’s own Q1 and H1/Q2 2026 releases (Half‑yearly financial statements 2026 and related news). For full detail, consult the published Half‑yearly financial statements 2026 and the Q1/Q2 statements for the exact adjusted calculations and underlying segment breakdowns.

Summarized from source with an LLMView Source

Key figures

-45.6%1Y
-5.33%3Y
-38.0%5Y

Performance

37.0%1Y
36.2%3Y
39.9%5Y

Volatility

Market cap

238 M

Market cap (USD)

Daily traded volume (Shares)

19,295

Daily traded volume (Shares)

1 day high/low

22.8 / 21.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Upstart Holdings Inc
Upstart Holdings Inc Upstart Holdings Inc Valor: 58052754
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.01%USD 23.86
Sea Ltd
Sea Ltd Sea Ltd Valor: 38497535
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.33%USD 96.53
discoverIE Group PLC
discoverIE Group PLC discoverIE Group PLC Valor: 368874
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.82%GBP 8.65
Novavax Inc
Novavax Inc Novavax Inc Valor: 47862952
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.87%USD 11.32
Kura Oncology Inc
Kura Oncology Inc Kura Oncology Inc Valor: 28160920
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.85%USD 10.53
Sana Biotechnology Inc
Sana Biotechnology Inc Sana Biotechnology Inc Valor: 59422986
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.51%USD 2.75
Koninklijke Philips NV
Koninklijke Philips NV Koninklijke Philips NV Valor: 1107280
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.00%USD 24.15
Prime Medicine Inc
Prime Medicine Inc Prime Medicine Inc Valor: 122054714
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
9.03%USD 3.50
Orbis SE
Orbis SE Orbis SE Valor: 1124238
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.87%EUR 4.66
Extreme Networks Inc
Extreme Networks Inc Extreme Networks Inc Valor: 653096
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.19%USD 24.54